BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27436448)

  • 1. Treatment of necrobiotic xanthogranuloma - a systematic review.
    Miguel D; Lukacs J; Illing T; Elsner P
    J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):221-235. PubMed ID: 27436448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xanthoma-like Skin Changes in an Elderly Woman with a Normal Lipid Profile.
    Nockowski P; Woźniak Z; Reich A; Maj J
    Acta Dermatovenerol Croat; 2017 Jul; 25(2):167-169. PubMed ID: 28871936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Multicenter Cross-Sectional Study and Systematic Review of Necrobiotic Xanthogranuloma With Proposed Diagnostic Criteria.
    Nelson CA; Zhong CS; Hashemi DA; Ashchyan HJ; Brown-Joel Z; Noe MH; Imadojemu S; Micheletti RG; Vleugels RA; Wanat KA; Rosenbach M; Mostaghimi A
    JAMA Dermatol; 2020 Mar; 156(3):270-279. PubMed ID: 31940000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of refractory necrobiotic xanthogranulomas with extracorporeal photopheresis and intravenous immunoglobulin.
    Liszewski W; Wisniewski JD; Safah H; Boh EE
    Dermatol Ther; 2014; 27(5):268-71. PubMed ID: 24910296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necrobiotic xanthogranuloma.
    Rose A; Robinson M; Kamino H; Latkowski JA
    Dermatol Online J; 2012 Dec; 18(12):30. PubMed ID: 23286820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic therapy of necrobiotic xanthogranuloma: a systematic review.
    Steinhelfer L; Kühnel T; Jägle H; Mayer S; Karrer S; Haubner F; Schreml S
    Orphanet J Rare Dis; 2022 Mar; 17(1):132. PubMed ID: 35331271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Necrobiotic xanthogranuloma.
    Fernández-Herrera J; Pedraz J
    Semin Cutan Med Surg; 2007 Jun; 26(2):108-13. PubMed ID: 17544963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Uveitis and Scleritis in Necrobiotic Xanthogranuloma.
    Gonzales JA; Haemel A; Gross AJ; Acharya NR
    J Ocul Pharmacol Ther; 2017 May; 33(4):325-333. PubMed ID: 28394239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Features and Treatment Outcomes of Patients With Necrobiotic Xanthogranuloma Associated With Monoclonal Gammopathies.
    Higgins LS; Go RS; Dingli D; Kumar SK; Rajkumar SV; Dispenzieri A; Buadi FK; Lacy MQ; Lust JA; Kapoor P; Leung N; Lin Y; Kourelis TV; Gertz MA; Kyle RA; Gonsalves WI
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16(8):447-52. PubMed ID: 27238425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Necrobiotic xanthogranuloma without a monoclonal gammopathy.
    Seastrom S; Bookout A; Hogan DJ
    Cutis; 2014 Dec; 94(6):293-6. PubMed ID: 25566570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First case report of pre-mortem biopsy-proven kidney involvement by necrobiotic xanthogranuloma with monoclonal gammopathy.
    Bleasel JM; Hopp JP; Cunningham I; Ritchie AG
    J Nephrol; 2022 Jul; 35(6):1753-1757. PubMed ID: 34739712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful multimodality treatment of recalcitrant necrobiotic xanthogranuloma using electron beam radiation and intravenous immunoglobulin.
    Nambudiri VE; McLaughlin C; Lo TC; Zembowicz A; Moschella S
    Clin Exp Dermatol; 2016 Mar; 41(2):179-82. PubMed ID: 26206141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necrobiotic Xanthogranuloma With Associated Monoclonal Gammopathy Presenting as an Eyelid Nodule.
    Punyamurthy NT; Tjahjono LA; Harris GJ; Wanat KA
    Ophthalmic Plast Reconstr Surg; 2023 Sep-Oct 01; 39(5):e148-e150. PubMed ID: 37279015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unusual histologic variant of necrobiotic xanthogranuloma.
    Ziemer M; Norgauer J; Simon JC; Koehler MJ
    Am J Dermatopathol; 2012 Apr; 34(2):e22-6. PubMed ID: 22441374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of necrobiotic xanthogranuloma - case series and review of the literature.
    Hansen I; Ghandili S; Abeck F; Booken N; Schneider SW
    J Dtsch Dermatol Ges; 2023 Nov; 21(11):1315-1318. PubMed ID: 37811744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete remission of necrobiotic xanthogranuloma after disappearance of monoclonal immunoglobulin induced by bortezomib, lenalidomid and dexamethasone.
    Adam Z; Pour L; Řehák Z; Dvořáková K; Koukalová R; Feit J; Kameník P; Krejčí M; Štork M; Krejčí M; Sandecká V; Boichuk I; Král Z
    Vnitr Lek; 2021; 67(6):352-356. PubMed ID: 35459378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Necrobiotic xanthogranuloma of the extremities with paraproteinemia and without periorbital involvement at presentation.
    Hashemi P; Rashidi A; Chapas AM; Balfour EM
    Cutis; 2012 Jan; 89(1):41-4. PubMed ID: 22439311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periorbital Necrobiotic Xanthogranuloma Successfully Treated with Intravenous Immunoglobulin.
    Olson RM; Harrison AR; Maltry A; Mokhtarzadeh A
    Case Rep Ophthalmol; 2018; 9(1):70-75. PubMed ID: 29643785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necrobiotic xanthogranuloma: a 30-year single-center experience.
    Hilal T; DiCaudo DJ; Connolly SM; Reeder CB
    Ann Hematol; 2018 Aug; 97(8):1471-1479. PubMed ID: 29568990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of necrobiotic xanthogranuloma with intravenous immunoglobulin.
    Rubinstein A; Wolf DJ; Granstein RD
    J Cutan Med Surg; 2013; 17(5):347-50. PubMed ID: 24067856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.